Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Texas medical technology incubator NTEC (North Texas Enterprise Center for Medical Technology) outgrows premises:

This article was originally published in Clinica

Executive Summary

The North Texas Enterprise Center for Medical Technology (NTEC) is planning to relocate from its 11,000 square feet of donated space at Hall Office Park in the city of Frisco to a 50,000-square-foot building. "The market is ready for this kind of space," said NTEC head Larry Carlton. Builders may be ready to start within two months, reports the Dallas Business Journal. NTEC was established to help the Frisco Economic Development Corporation cultivate businesses. One of them was the biodegradable peripheral vein stent developer TissueGen, which recently raised $1.2m with which to start animal trials in June. "Early-stage companies need this infrastructure, and there's not a lot of it around," said Mr Carlton, whose new centre is planned for Eldorado Parkway/Dallas North Tollway.

You may also be interested in...

ICH Syncs Reproductive Toxicity Guidance With Current Science

The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.

Stada Grabs GSK Brands In EU

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts